TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
LEGN

Legend Biotech Corp

Healthcare · Biotechnology

19.10$ +0.3% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Legend Biotech Corp (LEGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 1,029 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement LEGN
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
24 49 62 75 69 117 285 627 1,029
-0.1 – – 232 313 65 144 235 408
24 49 62 75 69 52 141 393 621
8.2 61 162 232 313 336 382 414 415
1.6 2.8 6.8 23 47 81 107 137 136
9.6 64 194 75 461 507 580 696 757
14 -1.5 -133 -313 -392 -456 -439 -303 -137
0.0 0.1 0.2 4.2 0.9 11 22 22 21
14 -1.6 -127 -308 -407 -446 -520 -158 -283
4.5 1.2 -26 -42 -3.6 0.6 -1.9 19 14
9.4 -2.8 -102 -266 -404 -446 -518 -177 -297
14 0.1 -129 -298 -392 -417 -478 -113 -232

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?